The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study
Authors
Keywords
-
Journal
INFLAMMATION RESEARCH
Volume 70, Issue 10-12, Pages 1233-1246
Publisher
Springer Science and Business Media LLC
Online
2021-09-29
DOI
10.1007/s00011-021-01507-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
- (2021) Obbina Abani et al. LANCET
- COVID-19 pandemic—a focused review for clinicians
- (2020) M. Cevik et al. CLINICAL MICROBIOLOGY AND INFECTION
- Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
- (2020) Ruggero Capra et al. European Journal of Internal Medicine
- Pathogenesis of COVID-19 from a cell biology perspective
- (2020) Robert J. Mason EUROPEAN RESPIRATORY JOURNAL
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab for treatment of mechanically ventilated patients with COVID-19
- (2020) Emily C Somers et al. CLINICAL INFECTIOUS DISEASES
- How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19
- (2020) Zachary R. McCaw et al. ANNALS OF INTERNAL MEDICINE
- Effects of tocilizumab on mortality in hospitalized patients with COVID-19: a multicentre cohort study
- (2020) Javier Martínez-Sanz et al. CLINICAL MICROBIOLOGY AND INFECTION
- Overview on the use of IL-6 agents in the treatment of patients with cytokine release syndrome (CRS) and pneumonitis related to COVID-19 disease
- (2020) Zeyun Zhou et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis
- (2020) Eric A. Coomes et al. REVIEWS IN MEDICAL VIROLOGY
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started